Replies to post #30319 on Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

I think the naming is just an FDA guideline to provide drug companies directions to name a product so it's less confusing to public which might result in mistakes. For example if there were two drugs with very similar names. It's nothing to be suspicious. It does show that FDA is still working with IPCI to get things moving.